Cite
Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β.
MLA
Jun Ohishi, et al. “Imatinib Mesylate Inhibits Cell Growth of Malignant Peripheral Nerve Sheath Tumors in Vitro and in Vivo through Suppression of PDGFR-β.” BMC Cancer, vol. 13, no. 1, June 2013, pp. 1–11. EBSCOhost, https://doi.org/10.1186/1471-2407-13-224.
APA
Jun Ohishi, Mikiko Aoki, Kazuki Nabeshima, Junji Suzumiya, Tamotsu Takeuchi, Akira Ogose, Michiyuki Hakozaki, Yuichi Yamashita, & Hiroshi Iwasaki. (2013). Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β. BMC Cancer, 13(1), 1–11. https://doi.org/10.1186/1471-2407-13-224
Chicago
Jun Ohishi, Mikiko Aoki, Kazuki Nabeshima, Junji Suzumiya, Tamotsu Takeuchi, Akira Ogose, Michiyuki Hakozaki, Yuichi Yamashita, and Hiroshi Iwasaki. 2013. “Imatinib Mesylate Inhibits Cell Growth of Malignant Peripheral Nerve Sheath Tumors in Vitro and in Vivo through Suppression of PDGFR-β.” BMC Cancer 13 (1): 1–11. doi:10.1186/1471-2407-13-224.